Sucampo Announces Third Quarter 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Sucampo Pharma (SCMP) Misses Q3 EPS by 1c; Boosts FY14 Earnings Outlook
November 6, 2014 6:46 AM ESTSucampo Pharma (NASDAQ: SCMP) reported Q3 EPS of $0.03, $0.01 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $31.5 million versus the consensus estimate of $26.11 million.
Sucampo raised its full year 2014 earnings guidance to $15.0 million to $20.0 million net income, excluding special items,... More
